Aug 29, 2023 21:01:21 GMT
Post by Sumi Okita on Aug 29, 2023 21:01:21 GMT
[nospaces]
[googlefont=Montserrat:200,300,400,700,800]
[googlefont=Hammersmith One]
[newclass=.opmind]padding:14px;border:solid 1px #e2e2e2;background-color:#f3f3f3;width:450px;color:#444444;text-align:justify;font:10px Verdana;[/newclass]
[newclass=.opmindtop]background-color:#c2517b;padding:1px;height:133px;[/newclass]
[newclass=.opmindtopp]background-color:#f5f5f5;opacity:.25;position:absolute;height:133px;width:448px;[/newclass]
[newclass=.opmindtopleft]border:solid 1px #c2517b;height:65px;width:60px;letter-spacing:-1px;padding-right:5px;background-color:#f5f5f5;float:left;margin:33px 0px 0px 33px;font:30px Montserrat;font-weight:300!important;line-height:65px;color:#c2517b;font-style:italic;text-align:center;position:relative;z-index:1;[/newclass]
[newclass=.opmindtopright]margin:33px 33px 0px 103px;border:solid 1px #c2517b;height:65px;background-color:#f5f5f5;color:#aaaaaa;font:30px Montserrat;line-height:65px;font-weight:200!important;text-transform:lowercase;font-style:italic;text-align:right;padding-right:25px;white-space:nowrap;overflow:hidden;position:relative;z-index:1;[/newclass]
[newclass=.opmindtop2]border:solid 1px #e2e2e2;background-color:#f9f9f9;border-top:none;padding:14px;font:10px Hammersmith One;text-align:right;text-transform:uppercase;font-style:italic;[/newclass]
[newclass=.opmindblurb]border-left:solid 1px #e2e2e2;border-right:solid 1px #e2e2e2;padding:6px;background-color:#eeeeee;[/newclass]
[newclass=.opmindblurb1]border:solid 1px #e2e2e2;background-color:#f9f9f9;padding:34px;[/newclass]
[newclass=.opmindblurb1 h1]font:27px Montserrat;color:#c2517b;font-weight:200!important;line-height:25px;font-style:italic;padding:20px 0px 20px 15px;text-transform:lowercase;[/newclass]
[newclass=.opmindblurb1 h2]font:10px Hammersmith One;color:#aaaaaa;font-style:italic;line-height:10px;margin-top:-15px;padding:0px 0px 20px 15px;text-transform:uppercase;[/newclass]
[newclass=.opmindblurb1 b]font:10px Hammersmith One;color:#aaaaaa;[/newclass]
[newclass=.opmindblurb1 a]font:10px Hammersmith One;color:#c2517b;[/newclass]
[newclass=.opmindblurb1 i]color:#aaaaaa;[/newclass]
[newclass=.opmindcode]border:solid 1px #e2e2e2;background-color:#f3f3f3;padding:24px;color:#aaaaaa;margin:20px 0px 0px 0px;font:10px Montserrat;font-weight:300!important;[/newclass]
[newclass=.opmindbot]background-color:#c2517b;padding:1px;[/newclass]
[newclass=.opmindbot div]height:15px;background-color:#f5f5f5;opacity:.25;[/newclass]
[attr="class","opmind"]
[attr="class","opmindtop"]
[attr="class","opmindtopp"]
[attr="class","opmindtopleft"]2015
[attr="class","opmindtopright"]TIAMAT
[attr="class","opmindtop2"]Build the first next-generation biotechnology company – one that expands the highest quality therapies to more people around the world – through courage, persistent innovation, and challenging the status quo.
[attr="class","opmindblurb"]
[attr="class","opmindblurb1"]
Tiamat Tech, more commonly known as Tiamat, is an international conglomerate that exists as one of the top pillars of the biotech industry. It had been several generations since it was created, initially a small business operating out of Kyushu near the coast. Founded in 2015 by Sumi Okita’s great-grandmother, its original focus was manufacturing drugs for rare conditions. Tiamat was one of the first major companies to embrace the new status quo and lean into quirk conditions at the onset of quirks. A bet that paid off in spades as over the next century, Tiamat expanded to be a worldwide company with over 83,000 employees across its many sites and an expected growth of 3% year to year.
As it was initially a smaller biotech company, the early focus of Tiamat was developing and producing medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. while these are still a critical part of the business, they've since expanded to incorporate quirk studies. They are a massive supplier of quirk-related data and the advancement of quirk science. They've dipped into every facet of science, from quirk-influencing drugs to molecular biology. If there's a scientific study or practice, there's a very high chance that Tiamat is either the developer or financier of this.
Sojiro Okita - Chairman and Chief Executive Officer[break][break]
Hideo Muto - Chief Corporate Affairs Officer, Executive Vice President[break][break]
Yoshiko Yamazaki - Chief Global Supply Officer, Executive Vice President[break][break]
Sumi Okita - Heiress/Senior Scientist of Honshu Division[break][break]
About
Tiamat Tech, more commonly known as Tiamat, is an international conglomerate that exists as one of the top pillars of the biotech industry. It had been several generations since it was created, initially a small business operating out of Kyushu near the coast. Founded in 2015 by Sumi Okita’s great-grandmother, its original focus was manufacturing drugs for rare conditions. Tiamat was one of the first major companies to embrace the new status quo and lean into quirk conditions at the onset of quirks. A bet that paid off in spades as over the next century, Tiamat expanded to be a worldwide company with over 83,000 employees across its many sites and an expected growth of 3% year to year.
production
As it was initially a smaller biotech company, the early focus of Tiamat was developing and producing medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. while these are still a critical part of the business, they've since expanded to incorporate quirk studies. They are a massive supplier of quirk-related data and the advancement of quirk science. They've dipped into every facet of science, from quirk-influencing drugs to molecular biology. If there's a scientific study or practice, there's a very high chance that Tiamat is either the developer or financier of this.
People
Sojiro Okita - Chairman and Chief Executive Officer[break][break]
Hideo Muto - Chief Corporate Affairs Officer, Executive Vice President[break][break]
Yoshiko Yamazaki - Chief Global Supply Officer, Executive Vice President[break][break]
Sumi Okita - Heiress/Senior Scientist of Honshu Division[break][break]
[attr="class","opmindbot"]
PHARAOH LEAP CREATES
[googlefont=Montserrat:200,300,400,700,800]
[googlefont=Hammersmith One]
[newclass=.opmind]padding:14px;border:solid 1px #e2e2e2;background-color:#f3f3f3;width:450px;color:#444444;text-align:justify;font:10px Verdana;[/newclass]
[newclass=.opmindtop]background-color:#c2517b;padding:1px;height:133px;[/newclass]
[newclass=.opmindtopp]background-color:#f5f5f5;opacity:.25;position:absolute;height:133px;width:448px;[/newclass]
[newclass=.opmindtopleft]border:solid 1px #c2517b;height:65px;width:60px;letter-spacing:-1px;padding-right:5px;background-color:#f5f5f5;float:left;margin:33px 0px 0px 33px;font:30px Montserrat;font-weight:300!important;line-height:65px;color:#c2517b;font-style:italic;text-align:center;position:relative;z-index:1;[/newclass]
[newclass=.opmindtopright]margin:33px 33px 0px 103px;border:solid 1px #c2517b;height:65px;background-color:#f5f5f5;color:#aaaaaa;font:30px Montserrat;line-height:65px;font-weight:200!important;text-transform:lowercase;font-style:italic;text-align:right;padding-right:25px;white-space:nowrap;overflow:hidden;position:relative;z-index:1;[/newclass]
[newclass=.opmindtop2]border:solid 1px #e2e2e2;background-color:#f9f9f9;border-top:none;padding:14px;font:10px Hammersmith One;text-align:right;text-transform:uppercase;font-style:italic;[/newclass]
[newclass=.opmindblurb]border-left:solid 1px #e2e2e2;border-right:solid 1px #e2e2e2;padding:6px;background-color:#eeeeee;[/newclass]
[newclass=.opmindblurb1]border:solid 1px #e2e2e2;background-color:#f9f9f9;padding:34px;[/newclass]
[newclass=.opmindblurb1 h1]font:27px Montserrat;color:#c2517b;font-weight:200!important;line-height:25px;font-style:italic;padding:20px 0px 20px 15px;text-transform:lowercase;[/newclass]
[newclass=.opmindblurb1 h2]font:10px Hammersmith One;color:#aaaaaa;font-style:italic;line-height:10px;margin-top:-15px;padding:0px 0px 20px 15px;text-transform:uppercase;[/newclass]
[newclass=.opmindblurb1 b]font:10px Hammersmith One;color:#aaaaaa;[/newclass]
[newclass=.opmindblurb1 a]font:10px Hammersmith One;color:#c2517b;[/newclass]
[newclass=.opmindblurb1 i]color:#aaaaaa;[/newclass]
[newclass=.opmindcode]border:solid 1px #e2e2e2;background-color:#f3f3f3;padding:24px;color:#aaaaaa;margin:20px 0px 0px 0px;font:10px Montserrat;font-weight:300!important;[/newclass]
[newclass=.opmindbot]background-color:#c2517b;padding:1px;[/newclass]
[newclass=.opmindbot div]height:15px;background-color:#f5f5f5;opacity:.25;[/newclass]